Home  Clinical trials Seloken ZOK/Toprol-XL™ (metoprolol CR/XL)
|
|
| Seloken ZOK / Toprol-XL™ (metoprolol CR/XL) Clinical Trial report summaries |
Seloken ZOK / Toprol-XL™ (metoprolol CR/XL) is a cardioselective beta-blocker for hypertension, angina pectoris, heart failure, disturbances of cardiac rhythm including especially supraventricular tachycardia, maintenance treatment after myocardial infarction and functional heart disorders with palpitations and for migraine prophylaxis.
Please consult the prescribing information for the country concerned for guidance on the approved use of Seloken ZOK / Toprol-XL™ (metoprolol CR/XL). | Study Number | Completed Clinical Trial Report Summaries | | D4025L00006 | An open-label, non-comparative, multi-centre study to evaluate the Efficacy and safety of Metoprolol Succinate prolonged-release tablet (Betaloc Zok) in patients with mild to moderate essential hypertensionure. | | SH-MET-0024 | Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure - MERIT-HF.
A Double-Blind, Placebo Controlled Survival Study with Metoprolol CR/XL in Patients with Decreased Ejection Fraction and Symptoms of Heart Failure. |
|
|
|
|